NCT06047990 (BICRYOB) is a NA clinical trial of Cryobiopsy catheter in Biliary Tract Carcinoma, sponsored by Brno University Hospital.

Who is sponsoring NCT06047990?

NCT06047990 is sponsored by Brno University Hospital.

What drugs are being tested in NCT06047990?

Interventions in NCT06047990: Cryobiopsy catheter.

What condition does NCT06047990 study?

NCT06047990 studies Biliary Tract Carcinoma, Biliary Obstruction.

Is NCT06047990 still recruiting?

NCT06047990 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06047990: BICRYOB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction

Status unknown NA Last updated 21 September 2023

What this trial tests

NA trial testing Cryobiopsy catheter in Biliary Tract Carcinoma in 20 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
31 July 2024

31 December 2024

Quick facts

Lead sponsor	Brno University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	diagnostic
Enrollment	20
Start date	1 June 2023
Primary completion	31 July 2024
Estimated completion	31 December 2024
Sites	1 location across Czechia

Drugs / interventions tested

Cryobiopsy catheter

Conditions studied

Biliary Tract Carcinoma — all drugs for Biliary Tract Carcinoma →
Biliary Obstruction — all drugs for Biliary Obstruction →

Sponsor

Brno University Hospital

Who can join

18 and older, any sex, with Biliary Tract Carcinoma or Biliary Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rationale of the study is to explore the safety and efficacy of percutaneously performed endobiliary cryobiopsy in patiens with histologically unverified biliary stenosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Percutaneous Endobiliary Cryobiopsy in Biliary Obstruction: Randomised Study (BICRYOB).
Rohan T, Hanžlová B, Matkulčík P, Vlažný J, et al · · 2026 · PMID 41345750 · DOI 10.1007/s00270-025-04282-6

Verify or expand the search:

Other recruiting trials for Biliary Tract Carcinoma

Currently open trials in the same condition.

NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
NCT06168292 — Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma · NA · recruiting
NCT06349044 — A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed · NA · recruiting
NCT05668884 — GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma · Phase 2 · recruiting
NCT05123482 — A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies · Phase 1, PHASE2 · recruiting

Other Brno University Hospital trials

Trials by the same sponsor.

NCT07468006 — Comparison of Transcutaneous and Blood CO₂ Measurement in Critically Ill Children · recruiting
NCT07280039 — Mortality and Muscle Mass Loss in Critically Ill Patients. · not yet recruiting
NCT07279701 — The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access · NA · recruiting
NCT07245654 — Monitoring the Depth of Anesthesia and Nociception During the Induction of General Anesthesia in Pediatric Patients · recruiting
NCT07110012 — The Role of Simulation-based Training in Resident Curriculum in Anaesthesia and Intensive Care · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06047990 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brno University Hospital
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06047990.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing